Publications
IDHDP has identified the publications listed below to be of interest to our members. The documents are displayed in alphabetical order.
Addressing Viral Hepatitis in People With Substance Use DisordersThis manual has been developed to provide behavioral health care programs offering substance abuse treatment services information to better address the needs of clients who have viral hepatitis. The manual was developed by the Substance Abuse and Mental Health Services Administration
Amphetamine Type Stimulants and Harm Reduction Problematic use of amphetamine-type stimulants (ATS)2 has become a significant health and social problem in East and Southeast Asia, in particular the use of methamphetamine, the most potent amphetamine
derivative and most widely used substance in the region.
Auf allen Linien gescheitertIn this interview, Kasia Malinowska-Sempruch discusses the negative impacts of the war on drugs, the role of current drug policies in fuelling the global HIV epidemic, and examples of successful drug policy reforms such as those introduced in Portugal and Switzerland
Briefing Paper: Heroin Assisted Treatment - The State of PlayThe United Nations Office on Drugs and Crime (UNODC) estimates that there are presently between 15.5 and 21.1 million opiate users in the world, the majority of whom are heroin users. There has been a growing awareness of the importance of treatment for this population in recent decades, with Opiate Substitution Therapy (OST) prominent amongst the range of treatment modalities.
Drug policy and the public good: evidence for effective interventionThe comprehensive review is the first of its kind to examine the effectiveness of all types of preventative drug policy worldwide, including policies to control the supply of drugs, prescription programmes to control pharmaceuticals, prevention programmes and health and social services for drug users.
"IDHDP endeavors to have a real impact on the policies that affect the way drug users are treated in our society. We are developing a well organised global network of medical doctors to become more involved in advocating for healthy drug policies. Additionally, we work with other harm reduction, health, and drug policy reform networks in helping to bridge the gap between practice and policy"